Results for tag: "Proquad"

Proquad is a vaccine used to protect against measles, mumps, rubella, and varicella (chickenpox). It is a combination vaccine, meaning it contains four different antigens in one injection. Proquad is approved for use in children aged 12 months to 12 years. It is administered as a single injection, and is usually given in two doses, with the second dose given four to six weeks after the first. The vaccine is designed to provide long-term protection against the four diseases. Proquad is a widely used vaccine, and is available in many countries around the world. It is typically administered in combination with other vaccines, such as the diphtheria, tetanus, and pertussis (DTaP) vaccine. Proquad is also used in combination with other vaccines to provide protection against multiple diseases. The Proquad market is highly competitive, with many companies offering their own versions of the vaccine. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more